Xin Lang Cai Jing·2025-10-27 07:12Core Viewpoint - The news highlights the initiation of investor compensation claims against Luqiao Information due to false statements and financial reporting violations, as well as ongoing claims against Xilong Science with previous successful judgments and settlements [1][2]. Group 1: Luqiao Information - Luqiao Information received a notice from the China Securities Regulatory Commission (CSRC) on October 14, 2025, regarding an investigation into financial information disclosure violations [1]. - The company acknowledged significant internal control deficiencies related to financial statements for the years 2023 and 2024, leading to inaccurate financial reporting [1]. - Investors who purchased Luqiao Information shares between April 23, 2024, and September 30, 2025, may initiate compensation claims [1]. Group 2: Xilong Science - Xilong Science is currently facing 204 investor lawsuits related to securities false statements, with a total claim amount of RMB 23.15 million [2]. - The company has been found to have inflated revenue and profits in its financial reports for the years 2020, 2021, and the first half of 2022, with significant percentages of total revenue and profit affected [2]. - Investors who bought Xilong Science shares between April 29, 2021, and April 29, 2023, are eligible to file compensation claims based on previous successful judgments [3].